ATE520418T1 - Antiinfektiöse lösung mit einer pyrido(3,2,1-ij)- benzoxadiazin-verbindung - Google Patents

Antiinfektiöse lösung mit einer pyrido(3,2,1-ij)- benzoxadiazin-verbindung

Info

Publication number
ATE520418T1
ATE520418T1 AT07731510T AT07731510T ATE520418T1 AT E520418 T1 ATE520418 T1 AT E520418T1 AT 07731510 T AT07731510 T AT 07731510T AT 07731510 T AT07731510 T AT 07731510T AT E520418 T1 ATE520418 T1 AT E520418T1
Authority
AT
Austria
Prior art keywords
gen
substituted
optionally
pyrido
benzoxadiazine
Prior art date
Application number
AT07731510T
Other languages
English (en)
Inventor
Marinette Moreau
Original Assignee
Vetoquinol Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vetoquinol Sa filed Critical Vetoquinol Sa
Application granted granted Critical
Publication of ATE520418T1 publication Critical patent/ATE520418T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines having two or more nitrogen atoms in the same ring, e.g. oxadiazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT07731510T 2006-01-24 2007-01-24 Antiinfektiöse lösung mit einer pyrido(3,2,1-ij)- benzoxadiazin-verbindung ATE520418T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0650246A FR2896416B1 (fr) 2006-01-24 2006-01-24 Composition anti-infectieuse comprenant un compose de type pyrido (3,2,1-ij)-benzoxadiazine
PCT/FR2007/050682 WO2007085760A2 (fr) 2006-01-24 2007-01-24 Solution anti-infectieuse comprenant un compose de type pyrido(3,2,1-ij)-benzoxadiazine

Publications (1)

Publication Number Publication Date
ATE520418T1 true ATE520418T1 (de) 2011-09-15

Family

ID=36748355

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07731510T ATE520418T1 (de) 2006-01-24 2007-01-24 Antiinfektiöse lösung mit einer pyrido(3,2,1-ij)- benzoxadiazin-verbindung

Country Status (25)

Country Link
US (1) US8796265B2 (de)
EP (2) EP2438929B1 (de)
JP (1) JP5221383B2 (de)
CN (1) CN101405032B (de)
AT (1) ATE520418T1 (de)
AU (1) AU2007209245B2 (de)
BR (1) BRPI0706956B1 (de)
CA (1) CA2637941C (de)
CY (1) CY1112481T1 (de)
DK (1) DK1976561T3 (de)
EA (1) EA016154B1 (de)
ES (2) ES2813856T3 (de)
FR (1) FR2896416B1 (de)
HK (1) HK1128883A1 (de)
HU (1) HUE050643T2 (de)
IL (1) IL192935A (de)
MX (1) MX2008009470A (de)
NO (1) NO20083422L (de)
NZ (1) NZ570332A (de)
PL (2) PL2438929T3 (de)
PT (2) PT1976561E (de)
SI (2) SI2438929T1 (de)
UA (1) UA94086C2 (de)
WO (1) WO2007085760A2 (de)
ZA (1) ZA200806369B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2928150A1 (fr) 2008-02-29 2009-09-04 Vetoquinol Sa Sa Nouveaux derives 7-substitues de 3-carboxy-oxadiazino-quinolones, leur preparation et leur application comme anti-bacteriens
EP2145891A1 (de) * 2008-07-09 2010-01-20 Vetoquinol S.A. 9-substierte 5-Carboxy-Oxadiazin-Chinolon-Derivate, ihre Herstellung und ihre Anwendung als antibakterielle Mittel
EP2332916A3 (de) 2009-11-19 2011-08-03 Krka Tovarna Zdravil, D.D., Novo Mesto Verfahren zur herstellung von marbofloxacin und intermediate davon
CN103271875A (zh) * 2013-07-01 2013-09-04 浙江华尔成生物药业股份有限公司 一种注射用麻保沙星冻干粉及其制备方法与应用
CN107107001B (zh) * 2014-12-31 2020-11-03 通用电气医疗集团生物科学公司 用于一次性生物反应器的轴安装式流体传递组件
US10440147B2 (en) 2015-11-24 2019-10-08 William Edward Woodcock, IV Quality-of-service management for domain name service
US20170239250A1 (en) 2016-02-19 2017-08-24 Eagle Pharmaceuticals, Inc. Pemetrexed formulations
CN107445977B (zh) * 2017-07-13 2019-08-09 江西傲新生物科技有限公司 一种水溶性马波沙星及其制备方法与应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3537761A1 (de) * 1985-10-24 1987-04-30 Bayer Ag Infusionsloesungen der 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-chinolin-3-carbonsaeure
ES2059335T3 (es) 1986-09-12 1994-11-16 Hoffmann La Roche Derivados de pirido(3,2,1-ij)-1,3,4-benzoxadiazina, procedimiento para su obtencion, preparados farmaceuticos correspondientes y productos intermedios utilizables en el procedimiento.
DE19500784A1 (de) * 1995-01-13 1996-07-18 Bayer Ag Enrofloxacin-Injektions- oder Infusionslösungen
DE19519822A1 (de) * 1995-05-31 1996-12-05 Bayer Ag Neue antibakterielle Mittel
EP0868183B1 (de) 1995-12-21 2002-01-30 Pfizer Inc. Injizierbare quinolonformulierungen
GB9600894D0 (en) * 1996-01-17 1996-03-20 Pfizer Novel compound
GB9600886D0 (en) * 1996-01-17 1996-03-20 Pfizer Novel compound
GB9601356D0 (en) * 1996-01-24 1996-03-27 Pfizer Novel compound
DE19633480A1 (de) * 1996-08-20 1998-02-26 Bayer Ag Oral applizierbare Formulierungen von Chinolon- und Naphthyridoncarbonsäuren
DE10337191A1 (de) * 2003-08-13 2005-03-17 Bayer Healthcare Ag Neue Verwendung von Chinolon-Antibiotika
CA2546195A1 (en) * 2003-11-21 2005-06-02 Pfizer Products Inc. The use of anti biotics as vaccine adjuvants

Also Published As

Publication number Publication date
MX2008009470A (es) 2008-09-23
CN101405032A (zh) 2009-04-08
SI2438929T1 (sl) 2020-10-30
NO20083422L (no) 2008-10-08
ES2813856T3 (es) 2021-03-25
EP2438929A2 (de) 2012-04-11
PT1976561E (pt) 2011-11-17
CA2637941A1 (fr) 2007-08-02
FR2896416A1 (fr) 2007-07-27
US8796265B2 (en) 2014-08-05
DK1976561T3 (da) 2011-12-05
WO2007085760A3 (fr) 2007-10-11
UA94086C2 (ru) 2011-04-11
ZA200806369B (en) 2009-08-26
CY1112481T1 (el) 2015-12-09
EP2438929B1 (de) 2020-06-10
NZ570332A (en) 2010-09-30
US20100280022A1 (en) 2010-11-04
BRPI0706956B1 (pt) 2019-08-13
EP2438929A3 (de) 2012-07-18
SI1976561T1 (sl) 2011-12-30
EP1976561A2 (de) 2008-10-08
PL2438929T3 (pl) 2020-12-14
IL192935A0 (en) 2009-02-11
FR2896416B1 (fr) 2010-08-13
HUE050643T2 (hu) 2020-12-28
BRPI0706956A2 (pt) 2011-04-12
IL192935A (en) 2014-02-27
AU2007209245A1 (en) 2007-08-02
WO2007085760A2 (fr) 2007-08-02
HK1128883A1 (en) 2009-11-13
PT2438929T (pt) 2020-09-01
JP2009523840A (ja) 2009-06-25
ES2371941T3 (es) 2012-01-11
PL1976561T3 (pl) 2012-01-31
EA200801733A1 (ru) 2008-12-30
EP1976561B1 (de) 2011-08-17
EA016154B1 (ru) 2012-02-28
JP5221383B2 (ja) 2013-06-26
CA2637941C (fr) 2014-01-21
AU2007209245B2 (en) 2013-09-12
CN101405032B (zh) 2013-01-16

Similar Documents

Publication Publication Date Title
CY1112481T1 (el) Αντι-μολυσματικο διαλυμα που περιλαμβανει μια ενωση του τυπου πυριδο(3,2,1-ij)-βενζοξαδιαζινης
MY148688A (en) 2-methylmorpholine pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mtor inhibitors
MX2007010072A (es) Derivados de piperidina antibacterianos.
TW200637839A (en) 1-thio-d-glucitol derivatives
MX2010009163A (es) Derivados heterociclicos de urea y metodos de uso de los mismos-211.
WO2008055870A8 (en) Glucopyranosyl-substituted benzyl-benzonitrile derivatives, medicaments containing such compounds, their use and process for their manufacture
WO2008034859A8 (en) Glucopyranosyl-substituted difluorobenzyl-benzene derivatives, medicaments containing such compounds, their use and process for their manufacture
MY162940A (en) Quinoline derivative-containing pharmaceutical composition
TW200833663A (en) Therapeutic agents
TW200502230A (en) Dual nk1/nk3 derivatives
TNSN08407A1 (en) Organic compounds
MX2009004096A (es) Metabolitos de talarozol.
SG159388A1 (en) Antibacterial agents
UA96964C2 (ru) Соединения полициклической мочевины с антибактериальными свойствами
MXPA05013712A (es) Derivados de acido propionico, utiles en el tratamiento de trastornos de lipidos.
TWI339659B (en) Aqueous composition comprising thiazole derivative
WO2008020227A3 (en) Antibacterial pyrrolecarboxamides
MX2010013310A (es) Derivados de heterociclil urea para el tratamiento de infecciones bacterianas.
UA96304C2 (en) 2-METHYLMORPHOLINE PYRIDO-, PYRAZO- AND PYRIMIDO-PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS
IL195837A0 (en) 4-amino-3-arylamino-6-arylpyrazolo[3,4-d]
MX2009012124A (es) Compuestos terapeuticos estereoisomeros de propofol.
SE0102057D0 (sv) New Salts I
MXPA04012685A (es) Derivados de acido benzoico orto-sustituidos para el tratamiento de la resistencia a la insulina.
SI1989208T1 (sl) Nove morfinske spojine za farmacevtske sestavke
MXPA05013717A (es) Derivados de acido 2-etoxi-2-fenilpropionico para el tratamiento de trastornos de lipido.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1976561

Country of ref document: EP